NZ554326A - Beclomethasone dipropionate (BDP) and prednisone for the treatment of graft-versus-host disease resulting from hematopoietic cell transplantation - Google Patents

Beclomethasone dipropionate (BDP) and prednisone for the treatment of graft-versus-host disease resulting from hematopoietic cell transplantation

Info

Publication number
NZ554326A
NZ554326A NZ554326A NZ55432605A NZ554326A NZ 554326 A NZ554326 A NZ 554326A NZ 554326 A NZ554326 A NZ 554326A NZ 55432605 A NZ55432605 A NZ 55432605A NZ 554326 A NZ554326 A NZ 554326A
Authority
NZ
New Zealand
Prior art keywords
bdp
day
treatment
prednisone
study
Prior art date
Application number
NZ554326A
Other languages
English (en)
Inventor
George B Mcdonald
Nicholas Stergiopoulos
Steve Kanzer
Original Assignee
Soligenix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soligenix Inc filed Critical Soligenix Inc
Publication of NZ554326A publication Critical patent/NZ554326A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Surgery (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NZ554326A 2004-12-30 2005-12-30 Beclomethasone dipropionate (BDP) and prednisone for the treatment of graft-versus-host disease resulting from hematopoietic cell transplantation NZ554326A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64017804P 2004-12-30 2004-12-30
PCT/US2005/047666 WO2006072093A2 (en) 2004-12-30 2005-12-30 Treatment of graft-versus-host disease and leukemia with beclomethasone dipropionate and prednisone

Publications (1)

Publication Number Publication Date
NZ554326A true NZ554326A (en) 2010-10-29

Family

ID=36615583

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ554326A NZ554326A (en) 2004-12-30 2005-12-30 Beclomethasone dipropionate (BDP) and prednisone for the treatment of graft-versus-host disease resulting from hematopoietic cell transplantation

Country Status (13)

Country Link
US (1) US20060252735A1 (cg-RX-API-DMAC7.html)
EP (1) EP1830857B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008526773A (cg-RX-API-DMAC7.html)
KR (1) KR20070089701A (cg-RX-API-DMAC7.html)
CN (2) CN102218070A (cg-RX-API-DMAC7.html)
AT (1) ATE481102T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005321826B2 (cg-RX-API-DMAC7.html)
CA (1) CA2583244A1 (cg-RX-API-DMAC7.html)
DE (1) DE602005023655D1 (cg-RX-API-DMAC7.html)
DK (1) DK1830857T3 (cg-RX-API-DMAC7.html)
IL (1) IL182462A0 (cg-RX-API-DMAC7.html)
NZ (1) NZ554326A (cg-RX-API-DMAC7.html)
WO (1) WO2006072093A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090143328A1 (en) * 2001-08-13 2009-06-04 Mcdonald George Method of Treating Cancer by Administration of Topical Active Corticosteroids
DK2902031T3 (en) * 2008-12-08 2019-01-14 Soligenix Inc Topically active steroid for use in radiation damage
US20170209447A1 (en) * 2014-08-07 2017-07-27 Nitor Therapeutics Use of PNP Inhibitor to Treat Relapse of Malignancy after Hematopoietic Stem Cell Transplant
CN106236736A (zh) * 2016-09-26 2016-12-21 安徽省逸欣铭医药科技有限公司 二丙酸倍氯米松肠溶缓释片及其制备方法
PH12022551401A1 (en) * 2019-12-09 2023-08-23 Syndax Pharmaceuticals Inc Antibodies for the treatment of chronic graft versus host disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096728A (en) * 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
US5747474A (en) * 1996-07-29 1998-05-05 Immune Modulation, Inc. Immunosuppression by administration of N6,N6 -disubstituted cAMP's, analogues thereof, and related nucleosides
US6096731A (en) * 1998-06-24 2000-08-01 Institute For Drug Research, Inc. Method for preventing tissue damage associated with graft-versus-host or host-versus-graft disease following transplantation
US20020086857A1 (en) * 2000-09-15 2002-07-04 Mcdonald George B. Method of long-term treatment of graft-versus-host disease using topical active corticosterioids
AU2002254205B2 (en) * 2001-03-15 2007-05-10 Enteron Pharmaceuticals, Inc. Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids
US20030032631A1 (en) * 2001-08-13 2003-02-13 Mcdonald George B. Method of treatment of cancer by controlling graft-versus-leukemia using topical active corticosteriods
JP4014912B2 (ja) * 2001-09-28 2007-11-28 株式会社ルネサステクノロジ 半導体装置

Also Published As

Publication number Publication date
DK1830857T3 (da) 2011-02-07
WO2006072093A3 (en) 2007-03-22
EP1830857A2 (en) 2007-09-12
DE602005023655D1 (de) 2010-10-28
EP1830857A4 (en) 2008-02-27
AU2005321826A1 (en) 2006-07-06
CA2583244A1 (en) 2006-07-06
AU2005321826B2 (en) 2012-03-15
US20060252735A1 (en) 2006-11-09
EP1830857B1 (en) 2010-09-15
CN101060848B (zh) 2011-06-22
ATE481102T1 (de) 2010-10-15
CN101060848A (zh) 2007-10-24
CN102218070A (zh) 2011-10-19
JP2008526773A (ja) 2008-07-24
KR20070089701A (ko) 2007-08-31
WO2006072093A2 (en) 2006-07-06
IL182462A0 (en) 2008-04-13

Similar Documents

Publication Publication Date Title
EP0893998B2 (en) Colonic delivery of nicotine to treat inflammatory bowel disease
KR101783577B1 (ko) 방사선 및 화학요법 손상에서 사용되는 국소적 활성 스테로이드
KR20160148050A (ko) 라퀴니모드를 이용한 크론병의 치료
US20230172936A1 (en) VCP/p97 INHIBITOR FOR THE TREATMENT OF CANCER
US20150141388A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease
Martin et al. Evaluation of oral beclomethasone dipropionate for prevention of acute graft-versus-host disease
US6096731A (en) Method for preventing tissue damage associated with graft-versus-host or host-versus-graft disease following transplantation
AU2005321826B2 (en) Treatment of graft-versus-host disease and leukemia with beclomethasone dipropionate and prednisone
CN117797149A (zh) 西达本胺联合r-chop的应用及联合药物
JP4326696B2 (ja) 糸球体腎炎の治療のための方法および手段
US20100184732A1 (en) Method of long-term treatment of graft-versus-host disease using topical active corticosteroids
TW202333731A (zh) 用於治療癌症之VCP/p97抑制劑
KR20230136603A (ko) S1p 수용체 조정제를 사용한 치료 방법
CN112672743A (zh) 肝病瘙痒症状的治疗
Scribano et al. medical treatment of moderate to severe Crohn's disease
CN116723835A (zh) 使用s1p受体调节剂的治疗方法
US20030032631A1 (en) Method of treatment of cancer by controlling graft-versus-leukemia using topical active corticosteriods
Katz Update in medical therapy in inflammatory bowel disease: a clinician’s view
US20020086857A1 (en) Method of long-term treatment of graft-versus-host disease using topical active corticosterioids
EA052496B1 (ru) Фармацевтическая композиция, содержащая модулятор рецептора s1p, и способ ее получения
TW202320788A (zh) 用於治療或預防抗宿主病的吡咯并六元雜芳物
EA052073B1 (ru) Ингибитор vcp/p97 для лечения рака
HK40113799A (zh) 用於治疗癌症的vcp/p97抑制剂
CN116529241A (zh) 治疗化脓性汗腺炎的方法
US20140328929A1 (en) Method of Preventing Acute Graft-Versus-Host Disease using Oral Beclomethasone Dipropionate

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: SOLIGENIX, US

Free format text: OLD OWNER(S): DOR BIOPHARMA, INC

PSEA Patent sealed
RENW Renewal (renewal fees accepted)
LAPS Patent lapsed